Tolerability and efficacy of perampanel in children with refractory epilepsy

Psychiatric and behavioral adverse events in randomized clinical studies of the noncompetitive AMPA receptor antagonist perampanel

(2015) Alan B. Ettinger et al.   EPILEPSIA

Perampanel in the treatment of partial seizures: Time to onset and duration of most common adverse events from pooled Phase III and extension studies

(2015) David Ko et al.   EPILEPSY & BEHAVIOR

Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel

(2015) Georgia Montouris et al.   EPILEPSY RESEARCH

Efficacy and safety of perampanel in adolescent patients with drug-resistant partial seizures in three double-blind, placebo-controlled, phase III randomized clinical studies and a combined extension study

(2015) William Rosenfeld et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy

(2015) Jacqueline A. French et al.   NEUROLOGY

Effectiveness and Tolerability of Perampanel in Children and Adolescents with Refractory Epilepsies: First Experiences

(2015) Ulrich Stephani et al.   NEUROPEDIATRICS

A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria

(2014) Bernhard J. Steinhoff et al.   EPILEPSY RESEARCH

Efficacy of perampanel: a review of clinical trial data

(2013) F. Kerling et al.   ACTA NEUROLOGICA SCANDINAVICA

Perampanel

(2012) Greg L. Plosker   CNS DRUGS

Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology

(2012) Marco Mula et al.   EPILEPSIA

Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

(2012) Jacqueline A. French et al.   EPILEPSIA

Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307

(2012) Gregory L. Krauss et al.   EPILEPSIA

Behavioral Adverse Effects of Antiepileptic Drugs in Epilepsy

(2012) Clare Margaret Eddy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Efficacy of antiepileptic drugs in adults predicts efficacy in children: A systematic review

(2012) J. M. Pellock et al.   NEUROLOGY

Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

(2012) J. A. French et al.   NEUROLOGY

Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures

(2012) G. L. Krauss et al.   NEUROLOGY

Tolerability and safety of perampanel: two randomized dose-escalation studies

(2011) G. L. Krauss et al.   ACTA NEUROLOGICA SCANDINAVICA

Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009

(2010) Anne T. Berg et al.   EPILEPSIA